Perceptive Advisors LLC purchased a new stake in CTI BioPharma Corp. ( NASDAQ:CTIC – Get Rating ) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 735,165 shares of the biopharmaceutical company's stock, valued at approximately $4,279,000. Perceptive Advisors LLC owned 0.58% of CTI BioPharma at the end of the most recent reporting period. Several other large investors have also recently bought and sold shares of CTIC.

https://www.dailypolitical.com/2023/03/07/735165-shares-in-cti-biopharma-corp-nasdaqctic-acquired-by-perceptive-advisors-llc.html

#dailypolitical